We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Investigation on the Role of Corticosteroids and Beta-Agonists on Cytokine Production in COPD Patients

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified July 2005 by St. Antonius Hospital.
Recruitment status was:  Recruiting
Sponsor:
ClinicalTrials.gov Identifier:
NCT00263380
First Posted: December 8, 2005
Last Update Posted: September 11, 2006
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
St. Antonius Hospital
  Purpose
Research on the synergistic effect of corticosteroids and beta-agonists on the cytokine production in COPD patients. Blood will be obtained from healthy volunteers and COPD patients and blood monocytes will be stimulated to produce cytokines with or without the prementioned drugs.

Condition
COPD

Study Type: Observational
Study Design: Observational Model: Case Control
Primary Purpose: Screening
Time Perspective: Longitudinal
Time Perspective: Prospective
Official Title: Experimental Study on the Role of Corticosteroids and Beta-Agonists on Cytokine Production in COPD Patients

Resource links provided by NLM:


Further study details as provided by St. Antonius Hospital:

Estimated Enrollment: 90
Study Start Date: October 2005
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   40 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • clinical COPD
  • smoking
  • age > 40 years

Exclusion Criteria:

  • age < 40 years
  • use of antibiotics, corticosteroids or beta-agonists
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00263380


Locations
Netherlands
St Antonius Hospital Recruiting
Nieuwegein, Utrecht, Netherlands, 3435 CM
Contact: Robert Ten Broeke, Dr    + 31 30 609111    r.broeke@kf-antoniusmesosgroep.nl   
Principal Investigator: Robert Ten Broeke, Dr         
St Antonius Hospital Recruiting
Nieuwegein, Utrecht, Netherlands, 3435 CM
Contact: Robert Ten Broeke, Dr    + 31 30 6091111    r.broeke@kf-antoniusmesosgroep.nl   
Sponsors and Collaborators
St. Antonius Hospital
Investigators
Principal Investigator: Robert Ten Broeke, Dr St. Antonius Hospital
  More Information

ClinicalTrials.gov Identifier: NCT00263380     History of Changes
Other Study ID Numbers: COPD IL8
First Submitted: December 7, 2005
First Posted: December 8, 2005
Last Update Posted: September 11, 2006
Last Verified: July 2005

Keywords provided by St. Antonius Hospital:
COPD
cytokines
corticosteroids
beta agonists
synergistic effect